Results 171 to 180 of about 31,062 (287)

LDL cholesterol and clinical outcomes in heart failure with reduced ejection fraction a competing risk analysis. [PDF]

Sci Rep
Wang Q, Liu Z, Zhou W, Wu G, Hu K, Su H, Yan J, Chen K.   +7 more
europepmc   +1 more source

Studying the trend of HbA1C changes with NYHA class with SGLT2i in HFrEF T2DM Indian patients - A post-hoc analysis of REMIT-HF

Shantanu Sengupta, Rahee Borulkar, P.B. Jayagopal, J.P.S. Sawhney, Ashwani Mehta, Satish Suryavanshi, Naveen Jamwal, Ambanna Gowda, Ramesh Dargad, Vinod Kapoor, Amit Bhate, Navya K. Antony, Mayur Jadhav, Sumit Bhushan, Sanjay Choudhari, Saiprasad Patil, Hanmant Barkate   +16 more
openalex   +1 more source

The utility of urine biomarkers in diuretic resistance prediction in heart failure hospitalization

ESC Heart Failure, EarlyView.
High urine pi‐GST concentration might be a marker for the development of loop diuretic resistance in patients with congestive heart failure hospitalization. Abstract Aims Loop diuretic resistance (LDR) in patients with heart failure hospitalization (HHF) is associated with worse clinical outcomes.
Tomasz Imiela, Piotr Poplawski, Beata Zaborska, Ewa Pilichowska‐Paszkiet, Anna M. Imiela, Tomasz Bednarczyk, Katarzyna Piszcz, Andrzej Budaj   +7 more
wiley   +1 more source

Indirect Annuloplasty for Functional Mitral Regurgitation: CINCH or CLIP? [PDF]

Struct Heart
Chen M, Krivoshei L, Taramasso M.
europepmc   +1 more source

Changes of calcium cycling in HFrEF and HFpEF

, 2023
Jian Shou, Yunlong Huo
openalex   +1 more source

The Vulnerable Phase of Heart Failure [PDF]

, 2018
Butler, Javed, Chioncel, Ovidiu, Collins, Sean, Gracia, Ely, Pang, Peter, Singh, Prabhjot   +5 more
core   +1 more source

Cardioimmunologic response patterns after an acute heart failure event: Design and first results of AHF‐ImmunoCS

ESC Heart Failure, EarlyView.
Abstract Aims We have previously shown that patients who develop heart‐reactive antibodies (HRAs) de novo after a heart failure (HF) hospitalization are at increased risk of adverse outcomes, lending weight to the hypothesis that B cells may play a pivotal role in HF progression.
Niklas Beyersdorf, Boshra Afshar, Dora Pelin, Maximilian Bauser, Elisa Kaiser, Janna Lamers, Jannika Pätkau, Mairin Heil, Dennis Göpfert, Hanna Hepp, Wafaa Al Hassan, Thomas Kerkau, Fabian Kerwagen, Roland Jahns, Valerie Boivin‐Jahns, Stefan Frantz, Gustavo Ramos, Ulrich Hofmann, Stefan Störk, Caroline Morbach   +19 more
wiley   +1 more source

Exercise Rehabilitation for Heart Failure and Associated Cardiomyopathies. [PDF]

Curr Cardiol Rep
Stahl ME, Weeldreyer NR, MacNamara JP, Lozano PFR, Allen JD.   +4 more
europepmc   +1 more source

Different determinants of exercise capacity in HFpEF compared to HFrEF [PDF]

, 2017
Arlind Batalli, Pranvera Ibrahimi, Ibadete Bytyçi, Artan Ahmeti, Edmond Haliti, Shpend Elezi, Michael Y. Henein, Gani Bajraktari   +7 more
openalex   +1 more source

Therapy gaps for patients with heart failure and reduced kidney function: A prospective cohort study

ESC Heart Failure, EarlyView.
In this prospective registry of 1401 heart failure outpatients, patients with eGFR <60 mL/min/1.73m2 had lower achievement of target RASi and MRA doses, with the lowest absolute use in patients with eGFR <30. Beta blockers were consistently prescribed across all heart failure phenotypes and kidney function.
Chen Hsiang Ma, Arthur Qi, Luke Gagnon, Kaiming Wang, Chandu Sadasivan, Anukul Ghimire, Matthew Cooper, Somkanya Tungsanga, Bonaventure Oguaju, Ben Vandermeer, Finlay A. McAlister, Aminu K. Bello, Gavin Y. Oudit   +12 more
wiley   +1 more source